US Bancorp
EVGN icon

US Bancorp’s Evogene EVGN Stock Holding History

US Bancorp’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15
Closed -$19 – 4090
2025
Q2 		$19 Hold
15
– – ﹤0.01% 4140
2025
Q1 		$19 Buy
+15
New +$23 ﹤0.01% 4168

Other funds holding EVGN

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

US Bancorp's EVGN Position: Q3 2025 in Review

US Bancorp sold out of Evogene (EVGN) in Q3 2025, closing a stake of 15 shares — an estimated $19 sold.

US Bancorp first reported a position in EVGN in Q1 2025 and held it in 2 quarters. The position peaked at $19 in Q2 2025. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2025.

  • US Bancorp reported no remaining Evogene position as of Q3 2025 after selling out during the quarter.
  • US Bancorp sold 15 Evogene shares in Q3 2025, an estimated $19.
  • US Bancorp first reported a position in Evogene in Q1 2025 and held it in 2 quarters.
  • US Bancorp's Evogene position peaked at $19 in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.